| PERSPECTIVE THERAPEUTICS |
| USA |
| Gesundheit |
| US46489V3024 / A40EDR |
| AAJ0 (Frankfurt) |
| FRA:AAJ0, ETR:AAJ0, AAJ0:GR |
| - |
| https://perspectivetherap.. |
|
Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is..
>Volltext.. |
| 436.26 Mio. EUR |
| 315.86 Mio. EUR |
| 0.77 Mio. EUR |
| -86.9 Mio. EUR |
| -89.34 Mio. EUR |
| -1.21 EUR |
| 2.82 Mio. EUR |
| 26.53 Mio. EUR |
| -71.46 Mio. EUR |
| 5.05 |
| -46.41% |
| -14.65% |
| - |
| - |
| - |
| - |
| PERSPECTIVE THERAPEUTICS, PERSPECTIVE THERAPEUTIC |
| 05.04.26 |
|